Rumination-focused cognitive behaviour therapy for residual depression: a case series

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Residual depression symptoms after acute treatment increase chronic depression risk and relapse.
• Depressive rumination is a key factor in depression onset and maintenance, persisting even after remission.
• Medication-refractory residual depression requires novel intervention strategies.

Purpose of the Study:

• To evaluate the efficacy of a cognitive-behavioural treatment (CBT) specifically targeting depressive rumination in medication-refractory residual depression.
• To provide initial data on a novel CBT approach for residual depression.
• To assess improvements in depressive symptoms, rumination, and comorbid disorders.

Main Methods:

• An open case series design was employed.
• Fourteen participants with medication-refractory residual depression received up to 12 weekly individual CBT sessions.
• Treatment focused on shifting unhelpful thinking styles using functional analysis, imagery, and behavioral experiments.

Main Results:

• Significant improvements were observed in depressive symptoms and rumination levels.
• 71% of participants responded to treatment (≥50% reduction on the Hamilton Depression Rating Scale).
• 50% of participants achieved full remission from depression.

Conclusions:

• Cognitive-behavioural therapy targeting depressive rumination shows promise as an effective treatment for medication-refractory residual depression.
• Addressing depressive rumination may lead to generalized improvements in depression and comorbid conditions.
• This approach offers a potential new intervention for a challenging patient group.